Early innate immune signatures correlate with Ad26.COV2.S vaccine durability and protective efficacy
Colarusso, A.; Stephenson, K.; Collier, A.-r.; Wegman, F.; Zahn, R. C.; Aid, M.; Barouch, D. H.
Show abstract
The innate immune system is rapidly activated following antigen exposure and plays a critical role in shaping the ensuing adaptive immune responses. In this study, we performed bulk RNA sequencing and proteomic profiling in a cohort of 25 rhesus macaques following Ad26.COV2.S immunization to characterize early innate correlates of vaccine immunogenicity and protection. Our results show that innate immune activation occurred as early as day 1 post-vaccination and demonstrated an systemic enrichment of antiviral interferon pathways, interleukin signaling, and innate immune cell signatures. These early transcriptomic signatures correlated positively with humoral and cellular immune responses at 6 weeks following vaccination and correlated inversely with viral loads following SARS-CoV-2 challenge. Similar correlates of immunogenicity were observed in a cohort of 25 adult healthy participants vaccinated with Ad26.COV2.S. Taken together, these findings highlight the importance of early activation of the innate immune system for Ad26.COV2.S vaccine immunogenicity and protective efficacy. Graphical SummaryGraphical summary of the model proposed by our findings. Day 1 innate immune signatures are protective of long-term protection. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=106 SRC="FIGDIR/small/731069v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@308acaorg.highwire.dtl.DTLVardef@e7e969org.highwire.dtl.DTLVardef@18d1a18org.highwire.dtl.DTLVardef@ac4fb0_HPS_FORMAT_FIGEXP M_FIG C_FIG IMPORTANCEEarly vaccine induction of innate immunity may be critical for vaccine immunogenicity and protective efficacy. In this study, we evaluated innate immune responses following Ad26.COV2.S vaccination in both rhesus macaques and humans. Early induction of innate immune signatures on day 1 following vaccination correlated with subsequent development of adaptive immune responses. These data suggest that the immune programming that occurs immediately after vaccination dictates immunogenicity weeks or months later.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Novel Oral Adjuvant to Enhance Cytotoxic Memory-Like NK Cell Responses in an HIV Vaccine Platform 96%
- Durability of DNA-LNP and mRNA-LNP Vaccine-Induced Immunity Against SARS-CoV-2 XBB.1.5 95%
- Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters 95%
Similar papers in this journal
- Heterologous vaccination with inactivated and mRNA vaccines increases B and T cell responses to SARS-CoV-2 95%
- SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques 95%
- Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization 95%
Similar papers in this journal
- Genetic immune response and antibody repertoire of heterologous ChAdOx1-BNT162b2 vaccination in a Korean cohort 96%
- BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine 96%
- Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates 95%
Similar papers in this journal
- GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR) 94%
- COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection 94%
- Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine 93%
Similar papers in this journal
- Robust immune response to the BNT162b mRNA vaccine in an elderly population vaccinated 15 months after recovery from COVID-19 96%
- Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice 95%
- SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.